Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Biosimilars: Accessible, affordable treatment

Biosimilars: Accessible, affordable treatment

en English

Complete this module today and earn yourself 1 CME Point.

Proceed to module  Shortlist  Rate Module  Share

en English

Summary This module explores current research on biosimilars used in cancer treatment

This module explores current research on biosimilars used in cancer treatment covering biosimilars and their forms, clinical standards and guidelines and the process of interchangeability and switching.

Published October 2018.

Target Audience

This resource is aimed mainly for physicians and pharmacists but extends to those who wish to know about biosimilars and how it can be used for cancer treatment.

Learning Objectives

By the end of this module, the learner should be able to:

  • Learn about biosimilars and their benefits of use for patients and physicians
  • Understand  the current landscape and guidelines
  • Learn about the clinical considerations in the use of biosimilars and the role of prescribers and pharmacists

This module awards the learner 1 CME point upon successful completion and passing of the assessment.

IT Requirements

This module requires the learner to have a good, stable internet connection and can run on Internet Explorer 7 and above, Mozilla Firefox, Google Chrome and Opera on either Windows or MacOS. Flash Add-on is also required to run this module.

If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatibility.

If you are experiencing technical difficulties, please contact education@ecancer.org and we will get back to you as soon as possible.

Commercial Support

Production of this module was funded by an unrestricted grant from Amgen.

Disclosure Policy

ecancer and everyone involved in the development of this module has no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this e-learning module which was made possible through an unrestricted educational grant from Amgen.

Proceed to Module

Relevant to the following professions

  • Industry
  • Nurse
  • Oncologist
  • Other
  • Public Health
  • Researcher
Proceed to module  Shortlist  Rate Module

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation